BioLight Life Sciences Ltd.

ILA 286.00As of Sun 8 Nov 2026, 12:00 UTC
TASE:BOLTHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (13.46%)
Div yield —
ROE (59.85%)
Biotechnology
Beta (5Y) 0.61
PE TTM —
TSR TTM (28.39%)
Mkt cap ILS 25.97M
ROIC (94.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 353
23.28%
(64.86%)
Hold 8|8|11|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
3.21
3.17
3.21
3.08
22.42%
27.24%
17.40%
6.89%
RevenueILS M
1.448
1.445
1.498
1.495
9.93%
8.63%
11.18%
6.79%
Peers (US$8.113M)
Cap (US$)
PE
9.333M
—
8.155M
0.687x
Capital
TTM
5Y
10Y
Leveragex
1.027
0.455
0.369
EBIT/Intx
0.667
0.174
0.160
Own earn%
40.32
(100.58)
(101.76)
Sh yield%
55.20
44.89
45.37
Owners
Insiders/Inst%
4.56
88.13
Short interest%
3.31
SBC / revenue%
2.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
30–36
$1 testx
−0.1
Incr. ROIC%
35